10,000 Shares in SPDR S&P Biotech ETF $XBI Bought by Dynamic Technology Lab Private Ltd

Dynamic Technology Lab Private Ltd bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, Holdings Channel reports. The fund bought 10,000 shares of the exchange traded fund’s stock, valued at approximately $1,219,000.

Several other institutional investors have also recently bought and sold shares of XBI. JPMorgan Chase & Co. raised its holdings in SPDR S&P Biotech ETF by 27.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after acquiring an additional 2,900,633 shares during the period. Wells Fargo & Company MN raised its holdings in SPDR S&P Biotech ETF by 75.7% in the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock worth $434,835,000 after acquiring an additional 1,536,122 shares during the period. Assetmark Inc. raised its holdings in SPDR S&P Biotech ETF by 1,042,265.6% in the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after acquiring an additional 635,782 shares during the period. Greenwoods Asset Management Hong Kong Ltd. bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth about $55,613,000. Finally, Ameriprise Financial Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 123.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares during the period.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $133.79 on Friday. The firm’s 50-day moving average is $132.63 and its 200-day moving average is $127.12. SPDR S&P Biotech ETF has a 52-week low of $80.90 and a 52-week high of $139.19. The company has a market cap of $8.54 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.